CellaVision AB Statistics

Total Valuation

CellaVision AB has a market cap or net worth of SEK 5.27 billion. The enterprise value is 5.17 billion.

Market Cap	5.27B
Enterprise Value	5.17B

Important Dates

The next estimated earnings date is Thursday, February 6, 2025.

Earnings Date	Feb 6, 2025
Ex-Dividend Date	n/a

Share Statistics

CellaVision AB has 23.85 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	23.85M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.90%
Owned by Institutions (%)	60.23%
Float	19.81M

Valuation Ratios

The trailing PE ratio is 35.09 and the forward PE ratio is 28.71. CellaVision AB's PEG ratio is 1.83.

PE Ratio	35.09
Forward PE	28.71
PS Ratio	7.15
PB Ratio	6.86
P/TBV Ratio	9.59
P/FCF Ratio	24.77
P/OCF Ratio	n/a
PEG Ratio	1.83

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.16, with an EV/FCF ratio of 24.29.

EV / Earnings	34.41
EV / Sales	7.01
EV / EBITDA	23.16
EV / EBIT	27.37
EV / FCF	24.29

Financial Position

The company has a current ratio of 3.04, with a Debt / Equity ratio of 0.05.

Current Ratio	3.04
Quick Ratio	2.15
Debt / Equity	0.05
Debt / EBITDA	0.16
Debt / FCF	0.17
Interest Coverage	114.06

Financial Efficiency

Return on equity (ROE) is 20.78% and return on invested capital (ROIC) is 15.16%.

Return on Equity (ROE)	20.78%
Return on Assets (ROA)	12.57%
Return on Capital (ROIC)	15.16%
Revenue Per Employee	3.23M
Profits Per Employee	658,829
Employee Count	228
Asset Turnover	0.78
Inventory Turnover	1.91

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.07% in the last 52 weeks. The beta is 1.11, so CellaVision AB's price volatility has been higher than the market average.

Beta (5Y)	1.11
52-Week Price Change	+8.07%
50-Day Moving Average	237.23
200-Day Moving Average	248.76
Relative Strength Index (RSI)	46.65
Average Volume (20 Days)	27,205

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CellaVision AB had revenue of SEK 737.16 million and earned 150.21 million in profits. Earnings per share was 6.30.

Revenue	737.16M
Gross Profit	493.83M
Operating Income	188.88M
Pretax Income	188.74M
Net Income	150.21M
EBITDA	211.18M
EBIT	188.88M
Earnings Per Share (EPS)	6.30

Full Income Statement

Balance Sheet

The company has 137.66 million in cash and 35.39 million in debt, giving a net cash position of 102.28 million or 4.29 per share.

Cash & Cash Equivalents	137.66M
Total Debt	35.39M
Net Cash	102.28M
Net Cash Per Share	4.29
Equity (Book Value)	767.86M
Book Value Per Share	32.19
Working Capital	264.16M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 228.87 million and capital expenditures -16.09 million, giving a free cash flow of 212.77 million.

Operating Cash Flow	228.87M
Capital Expenditures	-16.09M
Free Cash Flow	212.77M
FCF Per Share	8.92

Full Cash Flow Statement

Margins

Gross margin is 66.99%, with operating and profit margins of 25.62% and 20.38%.

Gross Margin	66.99%
Operating Margin	25.62%
Pretax Margin	25.60%
Profit Margin	20.38%
EBITDA Margin	28.65%
EBIT Margin	25.62%
FCF Margin	28.86%

Dividends & Yields

This stock pays an annual dividend of 2.25, which amounts to a dividend yield of 1.02%.

Dividend Per Share	2.25
Dividend Yield	1.02%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	35.73%
Buyback Yield	n/a
Shareholder Yield	1.02%
Earnings Yield	2.85%
FCF Yield	4.04%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a